Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Insights, Forecast to 2031

Report ID: 1654000 | Published Date: Jan 2025 | No. of Page: 111 | Base Year: 2024 | Rating: 3.8 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Business Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 CINV
        1.2.3 PONV
    1.3 Market by Application
        1.3.1 Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Hospitals
        1.3.3 Ambulatory Surgical Centers
        1.3.4 Diagnostic Centers
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Perspective (2017-2028)
    2.2 Chemotherapy-Induced Nausea and Vomiting (CINV) Growth Trends by Region
        2.2.1 Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Chemotherapy-Induced Nausea and Vomiting (CINV) Historic Market Size by Region (2017-2022)
        2.2.3 Chemotherapy-Induced Nausea and Vomiting (CINV) Forecasted Market Size by Region (2023-2028)
    2.3 Chemotherapy-Induced Nausea and Vomiting (CINV) Market Dynamics
        2.3.1 Chemotherapy-Induced Nausea and Vomiting (CINV) Industry Trends
        2.3.2 Chemotherapy-Induced Nausea and Vomiting (CINV) Market Drivers
        2.3.3 Chemotherapy-Induced Nausea and Vomiting (CINV) Market Challenges
        2.3.4 Chemotherapy-Induced Nausea and Vomiting (CINV) Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Chemotherapy-Induced Nausea and Vomiting (CINV) Players by Revenue
        3.1.1 Global Top Chemotherapy-Induced Nausea and Vomiting (CINV) Players by Revenue (2017-2022)
        3.1.2 Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Market Share by Players (2017-2022)
    3.2 Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue
    3.4 Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Concentration Ratio
        3.4.1 Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue in 2021
    3.5 Chemotherapy-Induced Nausea and Vomiting (CINV) Key Players Head office and Area Served
    3.6 Key Players Chemotherapy-Induced Nausea and Vomiting (CINV) Product Solution and Service
    3.7 Date of Enter into Chemotherapy-Induced Nausea and Vomiting (CINV) Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Chemotherapy-Induced Nausea and Vomiting (CINV) Breakdown Data by Type
    4.1 Global Chemotherapy-Induced Nausea and Vomiting (CINV) Historic Market Size by Type (2017-2022)
    4.2 Global Chemotherapy-Induced Nausea and Vomiting (CINV) Forecasted Market Size by Type (2023-2028)
5 Chemotherapy-Induced Nausea and Vomiting (CINV) Breakdown Data by Application
    5.1 Global Chemotherapy-Induced Nausea and Vomiting (CINV) Historic Market Size by Application (2017-2022)
    5.2 Global Chemotherapy-Induced Nausea and Vomiting (CINV) Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size (2017-2028)
    6.2 North America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Type
        6.2.1 North America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Type (2017-2022)
        6.2.2 North America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Type (2023-2028)
        6.2.3 North America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Share by Type (2017-2028)
    6.3 North America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Application
        6.3.1 North America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Application (2017-2022)
        6.3.2 North America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Application (2023-2028)
        6.3.3 North America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Share by Application (2017-2028)
    6.4 North America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Country
        6.4.1 North America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Country (2017-2022)
        6.4.2 North America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Country (2023-2028)
        6.4.3 U.S.
        6.4.4 Canada
7 Europe
    7.1 Europe Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size (2017-2028)
    7.2 Europe Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Type
        7.2.1 Europe Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Type (2017-2022)
        7.2.2 Europe Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Type (2023-2028)
        7.2.3 Europe Chemotherapy-Induced Nausea and Vomiting (CINV) Market Share by Type (2017-2028)
    7.3 Europe Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Application
        7.3.1 Europe Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Application (2017-2022)
        7.3.2 Europe Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Application (2023-2028)
        7.3.3 Europe Chemotherapy-Induced Nausea and Vomiting (CINV) Market Share by Application (2017-2028)
    7.4 Europe Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Country
        7.4.1 Europe Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Country (2017-2022)
        7.4.2 Europe Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Country (2023-2028)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size (2017-2028)
    8.2 Asia-Pacific Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Type
        8.2.1 Asia-Pacific Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Type (2017-2022)
        8.2.2 Asia-Pacific Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Type (2023-2028)
        8.2.3 Asia-Pacific Chemotherapy-Induced Nausea and Vomiting (CINV) Market Share by Type (2017-2028)
    8.3 Asia-Pacific Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Application
        8.3.1 Asia-Pacific Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Application (2017-2022)
        8.3.2 Asia-Pacific Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Application (2023-2028)
        8.3.3 Asia-Pacific Chemotherapy-Induced Nausea and Vomiting (CINV) Market Share by Application (2017-2028)
    8.4 Asia-Pacific Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Region
        8.4.1 Asia-Pacific Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Region (2017-2022)
        8.4.2 Asia-Pacific Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Region (2023-2028)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia 
9 Latin America
    9.1 Latin America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size (2017-2028)
    9.2 Latin America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Type
        9.2.1 Latin America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Type (2017-2022)
        9.2.2 Latin America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Type (2023-2028)
        9.2.3 Latin America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Share by Type (2017-2028)
    9.3 Latin America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Application
        9.3.1 Latin America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Application (2017-2022)
        9.3.2 Latin America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Application (2023-2028)
        9.3.3 Latin America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Share by Application (2017-2028)
    9.4 Latin America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Country
        9.4.1 Latin America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Country (2017-2022)
        9.4.2 Latin America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Country (2023-2028)
        9.4.3 Mexico
        9.4.4 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size (2017-2028)
    10.2 Middle East & Africa Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Type
        10.2.1 Middle East & Africa Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Type (2017-2022)
        10.2.2 Middle East & Africa Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Type (2023-2028)
        10.2.3 Middle East & Africa Chemotherapy-Induced Nausea and Vomiting (CINV) Market Share by Type (2017-2028)
    10.3 Middle East & Africa Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Application
        10.3.1 Middle East & Africa Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Application (2017-2022)
        10.3.2 Middle East & Africa Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Application (2023-2028)
        10.3.3 Middle East & Africa Chemotherapy-Induced Nausea and Vomiting (CINV) Market Share by Application (2017-2028)
    10.4 Middle East & Africa Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Country
        10.4.1 Middle East & Africa Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Country (2017-2022)
        10.4.2 Middle East & Africa Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Country (2023-2028)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE
11 Key Players Profiles
    11.1 Merck
        11.1.1 Merck Company Details
        11.1.2 Merck Business Overview
        11.1.3 Merck Chemotherapy-Induced Nausea and Vomiting (CINV) Introduction
        11.1.4 Merck Revenue in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2017-2022)
        11.1.5 Merck Recent Developments
    11.2 Eisai
        11.2.1 Eisai Company Details
        11.2.2 Eisai Business Overview
        11.2.3 Eisai Chemotherapy-Induced Nausea and Vomiting (CINV) Introduction
        11.2.4 Eisai Revenue in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2017-2022)
        11.2.5 Eisai Recent Developments
    11.3 ProStrakan
        11.3.1 ProStrakan Company Details
        11.3.2 ProStrakan Business Overview
        11.3.3 ProStrakan Chemotherapy-Induced Nausea and Vomiting (CINV) Introduction
        11.3.4 ProStrakan Revenue in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2017-2022)
        11.3.5 ProStrakan Recent Developments
    11.4 Helsinn Holding
        11.4.1 Helsinn Holding Company Details
        11.4.2 Helsinn Holding Business Overview
        11.4.3 Helsinn Holding Chemotherapy-Induced Nausea and Vomiting (CINV) Introduction
        11.4.4 Helsinn Holding Revenue in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2017-2022)
        11.4.5 Helsinn Holding Recent Developments
    11.5 Mundipharma
        11.5.1 Mundipharma Company Details
        11.5.2 Mundipharma Business Overview
        11.5.3 Mundipharma Chemotherapy-Induced Nausea and Vomiting (CINV) Introduction
        11.5.4 Mundipharma Revenue in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2017-2022)
        11.5.5 Mundipharma Recent Developments
    11.6 Qilu Pharma
        11.6.1 Qilu Pharma Company Details
        11.6.2 Qilu Pharma Business Overview
        11.6.3 Qilu Pharma Chemotherapy-Induced Nausea and Vomiting (CINV) Introduction
        11.6.4 Qilu Pharma Revenue in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2017-2022)
        11.6.5 Qilu Pharma Recent Developments
    11.7 Teva
        11.7.1 Teva Company Details
        11.7.2 Teva Business Overview
        11.7.3 Teva Chemotherapy-Induced Nausea and Vomiting (CINV) Introduction
        11.7.4 Teva Revenue in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2017-2022)
        11.7.5 Teva Recent Developments
    11.8 Novartis
        11.8.1 Novartis Company Details
        11.8.2 Novartis Business Overview
        11.8.3 Novartis Chemotherapy-Induced Nausea and Vomiting (CINV) Introduction
        11.8.4 Novartis Revenue in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2017-2022)
        11.8.5 Novartis Recent Developments
    11.9 Heron Therapeutics
        11.9.1 Heron Therapeutics Company Details
        11.9.2 Heron Therapeutics Business Overview
        11.9.3 Heron Therapeutics Chemotherapy-Induced Nausea and Vomiting (CINV) Introduction
        11.9.4 Heron Therapeutics Revenue in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2017-2022)
        11.9.5 Heron Therapeutics Recent Developments
    11.10 Roche
        11.10.1 Roche Company Details
        11.10.2 Roche Business Overview
        11.10.3 Roche Chemotherapy-Induced Nausea and Vomiting (CINV) Introduction
        11.10.4 Roche Revenue in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2017-2022)
        11.10.5 Roche Recent Developments
    11.11 Mylan
        11.11.1 Mylan Company Details
        11.11.2 Mylan Business Overview
        11.11.3 Mylan Chemotherapy-Induced Nausea and Vomiting (CINV) Introduction
        11.11.4 Mylan Revenue in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2017-2022)
        11.11.5 Mylan Recent Developments
    11.12 Tesaro
        11.12.1 Tesaro Company Details
        11.12.2 Tesaro Business Overview
        11.12.3 Tesaro Chemotherapy-Induced Nausea and Vomiting (CINV) Introduction
        11.12.4 Tesaro Revenue in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2017-2022)
        11.12.5 Tesaro Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Author Details
    13.3 Disclaimer

List of Tables
    Table 1. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of CINV
    Table 3. Key Players of PONV
    Table 4. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 5. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 6. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Region (2017-2022) & (US$ Million)
    Table 7. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Share by Region (2017-2022)
    Table 8. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 9. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Share by Region (2023-2028)
    Table 10. Chemotherapy-Induced Nausea and Vomiting (CINV) Market Trends
    Table 11. Chemotherapy-Induced Nausea and Vomiting (CINV) Market Drivers
    Table 12. Chemotherapy-Induced Nausea and Vomiting (CINV) Market Challenges
    Table 13. Chemotherapy-Induced Nausea and Vomiting (CINV) Market Restraints
    Table 14. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue by Players (2017-2022) & (US$ Million)
    Table 15. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Share by Players (2017-2022)
    Table 16. Global Top Chemotherapy-Induced Nausea and Vomiting (CINV) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chemotherapy-Induced Nausea and Vomiting (CINV) as of 2021)
    Table 17. Ranking of Global Top Chemotherapy-Induced Nausea and Vomiting (CINV) Companies by Revenue (US$ Million) in 2021
    Table 18. Global 5 Largest Players Market Share by Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue (CR5 and HHI) & (2017-2022)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Chemotherapy-Induced Nausea and Vomiting (CINV) Product Solution and Service
    Table 21. Date of Enter into Chemotherapy-Induced Nausea and Vomiting (CINV) Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Type (2017-2022) & (US$ Million)
    Table 24. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Market Share by Type (2017-2022)
    Table 25. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 26. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Market Share by Type (2023-2028)
    Table 27. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Application (2017-2022) & (US$ Million)
    Table 28. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Share by Application (2017-2022)
    Table 29. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 30. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Share by Application (2023-2028)
    Table 31. North America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Type (2017-2022) & (US$ Million)
    Table 32. North America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Type (2023-2028) & (US$ Million)
    Table 33. North America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Application (2017-2022) & (US$ Million)
    Table 34. North America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Application (2023-2028) & (US$ Million)
    Table 35. North America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Country (2017-2022) & (US$ Million)
    Table 36. North America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Country (2023-2028) & (US$ Million)
    Table 37. Europe Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Type (2017-2022) & (US$ Million)
    Table 38. Europe Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Type (2023-2028) & (US$ Million)
    Table 39. Europe Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Application (2017-2022) & (US$ Million)
    Table 40. Europe Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Application (2023-2028) & (US$ Million)
    Table 41. Europe Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Country (2017-2022) & (US$ Million)
    Table 42. Europe Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Country (2023-2028) & (US$ Million)
    Table 43. Asia Pacific Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Type (2017-2022) & (US$ Million)
    Table 44. Asia Pacific Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Type (2023-2028) & (US$ Million)
    Table 45. Asia Pacific Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Application (2017-2022) & (US$ Million)
    Table 46. Asia Pacific Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Application (2023-2028) & (US$ Million)
    Table 47. Asia Pacific Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Region (2017-2022) & (US$ Million)
    Table 48. Asia Pacific Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Region (2023-2028) & (US$ Million)
    Table 49. Latin America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Type (2017-2022) & (US$ Million)
    Table 50. Latin America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Type (2023-2028) & (US$ Million)
    Table 51. Latin America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Application (2017-2022) & (US$ Million)
    Table 52. Latin America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Application (2023-2028) & (US$ Million)
    Table 53. Latin America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Country (2017-2022) & (US$ Million)
    Table 54. Latin America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Country (2023-2028) & (US$ Million)
    Table 55. Middle East and Africa Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Type (2017-2022) & (US$ Million)
    Table 56. Middle East and Africa Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Type (2023-2028) & (US$ Million)
    Table 57. Middle East and Africa Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Application (2017-2022) & (US$ Million)
    Table 58. Middle East and Africa Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Application (2023-2028) & (US$ Million)
    Table 59. Middle East and Africa Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Country (2017-2022) & (US$ Million)
    Table 60. Middle East and Africa Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Country (2023-2028) & (US$ Million)
    Table 61. Merck Company Details
    Table 62. Merck Business Overview
    Table 63. Merck Chemotherapy-Induced Nausea and Vomiting (CINV) Product
    Table 64. Merck Revenue in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2017-2022) & (US$ Million)
    Table 65. Merck Recent Developments
    Table 66. Eisai Company Details
    Table 67. Eisai Business Overview
    Table 68. Eisai Chemotherapy-Induced Nausea and Vomiting (CINV) Product
    Table 69. Eisai Revenue in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2017-2022) & (US$ Million)
    Table 70. Eisai Recent Developments
    Table 71. ProStrakan Company Details
    Table 72. ProStrakan Business Overview
    Table 73. ProStrakan Chemotherapy-Induced Nausea and Vomiting (CINV) Product
    Table 74. ProStrakan Revenue in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2017-2022) & (US$ Million)
    Table 75. ProStrakan Recent Developments
    Table 76. Helsinn Holding Company Details
    Table 77. Helsinn Holding Business Overview
    Table 78. Helsinn Holding Chemotherapy-Induced Nausea and Vomiting (CINV) Product
    Table 79. Helsinn Holding Revenue in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2017-2022) & (US$ Million)
    Table 80. Helsinn Holding Recent Developments
    Table 81. Mundipharma Company Details
    Table 82. Mundipharma Business Overview
    Table 83. Mundipharma Chemotherapy-Induced Nausea and Vomiting (CINV) Product
    Table 84. Mundipharma Revenue in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2017-2022) & (US$ Million)
    Table 85. Mundipharma Recent Developments
    Table 86. Qilu Pharma Company Details
    Table 87. Qilu Pharma Business Overview
    Table 88. Qilu Pharma Chemotherapy-Induced Nausea and Vomiting (CINV) Product
    Table 89. Qilu Pharma Revenue in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2017-2022) & (US$ Million)
    Table 90. Qilu Pharma Recent Developments
    Table 91. Teva Company Details
    Table 92. Teva Business Overview
    Table 93. Teva Chemotherapy-Induced Nausea and Vomiting (CINV) Product
    Table 94. Teva Revenue in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2017-2022) & (US$ Million)
    Table 95. Teva Recent Developments
    Table 96. Novartis Company Details
    Table 97. Novartis Business Overview
    Table 98. Novartis Chemotherapy-Induced Nausea and Vomiting (CINV) Product
    Table 99. Novartis Revenue in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2017-2022) & (US$ Million)
    Table 100. Novartis Recent Developments
    Table 101. Heron Therapeutics Company Details
    Table 102. Heron Therapeutics Business Overview
    Table 103. Heron Therapeutics Chemotherapy-Induced Nausea and Vomiting (CINV) Product
    Table 104. Heron Therapeutics Revenue in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2017-2022) & (US$ Million)
    Table 105. Heron Therapeutics Recent Developments
    Table 106. Roche Company Details
    Table 107. Roche Business Overview
    Table 108. Roche Chemotherapy-Induced Nausea and Vomiting (CINV) Product
    Table 109. Roche Revenue in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2017-2022) & (US$ Million)
    Table 110. Roche Recent Developments
    Table 111. Mylan Company Details
    Table 112. Mylan Business Overview
    Table 113. Mylan Chemotherapy-Induced Nausea and Vomiting (CINV) Product
    Table 114. Mylan Revenue in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2017-2022) & (US$ Million)
    Table 115. Mylan Recent Developments
    Table 116. Tesaro Company Details
    Table 117. Tesaro Business Overview
    Table 118. Tesaro Chemotherapy-Induced Nausea and Vomiting (CINV) Product
    Table 119. Tesaro Revenue in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2017-2022) & (US$ Million)
    Table 120. Tesaro Recent Developments
    Table 121. Research Programs/Design for This Report
    Table 122. Key Data Information from Secondary Sources
    Table 123. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Share by Type: 2021 VS 2028
    Figure 2. CINV Features
    Figure 3. PONV Features
    Figure 4. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Share by Application: 2021 VS 2028
    Figure 5. Hospitals Case Studies
    Figure 6. Ambulatory Surgical Centers Case Studies
    Figure 7. Diagnostic Centers Case Studies
    Figure 8. Chemotherapy-Induced Nausea and Vomiting (CINV) Report Years Considered
    Figure 9. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 10. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 11. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Share by Region: 2021 VS 2028
    Figure 12. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Share by Players in 2021
    Figure 13. Global Top Chemotherapy-Induced Nausea and Vomiting (CINV) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chemotherapy-Induced Nausea and Vomiting (CINV) as of 2021)
    Figure 14. The Top 10 and 5 Players Market Share by Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue in 2021
    Figure 15. North America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size YoY (2017-2028) & (US$ Million)
    Figure 16. North America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size Market Share by Type (2017-2028)
    Figure 17. North America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size Market Share by Application (2017-2028)
    Figure 18. North America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size Share by Country (2017-2028)
    Figure 19. United States Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. Canada Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Europe Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size YoY (2017-2028) & (US$ Million)
    Figure 22. Europe Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size Market Share by Type (2017-2028)
    Figure 23. Europe Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size Market Share by Application (2017-2028)
    Figure 24. Europe Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size Share by Country (2017-2028)
    Figure 25. Germany Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. France Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. U.K. Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Italy Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Russia Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Nordic Countries Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Asia-Pacific Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size YoY (2017-2028) & (US$ Million)
    Figure 32. Asia Pacific Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size Market Share by Type (2017-2028)
    Figure 33. Asia Pacific Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size Market Share by Application (2017-2028)
    Figure 34. Asia Pacific Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size Share by Region (2017-2028)
    Figure 35. China Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Japan Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. South Korea Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Southeast Asia Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. India Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Australia Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
    Figure 41. Latin America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size YoY (2017-2028) & (US$ Million)
    Figure 42. Latin America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size Market Share by Type (2017-2028)
    Figure 43. Latin America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size Market Share by Application (2017-2028)
    Figure 44. Latin America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size Share by Country (2017-2028)
    Figure 45. Mexico Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 46. Brazil Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 47. Middle East & Africa Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size YoY (2017-2028) & (US$ Million)
    Figure 48. Middle East and Africa Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size Market Share by Type (2017-2028)
    Figure 49. Middle East and Africa Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size Market Share by Application (2017-2028)
    Figure 50. Middle East and Africa Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size Share by Country (2017-2028)
    Figure 51. Turkey Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 52. Saudi Arabia Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 53. UAE Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 54. Merck Revenue Growth Rate in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2017-2022)
    Figure 55. Eisai Revenue Growth Rate in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2017-2022)
    Figure 56. ProStrakan Revenue Growth Rate in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2017-2022)
    Figure 57. Helsinn Holding Revenue Growth Rate in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2017-2022)
    Figure 58. Mundipharma Revenue Growth Rate in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2017-2022)
    Figure 59. Qilu Pharma Revenue Growth Rate in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2017-2022)
    Figure 60. Teva Revenue Growth Rate in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2017-2022)
    Figure 61. Novartis Revenue Growth Rate in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2017-2022)
    Figure 62. Heron Therapeutics Revenue Growth Rate in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2017-2022)
    Figure 63. Roche Revenue Growth Rate in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2017-2022)
    Figure 64. Mylan Revenue Growth Rate in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2017-2022)
    Figure 65. Tesaro Revenue Growth Rate in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2017-2022)
    Figure 66. Bottom-up and Top-down Approaches for This Report
    Figure 67. Data Triangulation
    Figure 68. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Merck
Eisai
ProStrakan
Helsinn Holding
Mundipharma
Qilu Pharma
Teva
Novartis
Heron Therapeutics
Roche
Mylan
Tesaro
Frequently Asked Questions
Chemotherapy-Induced Nausea and Vomiting (CINV) report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Chemotherapy-Induced Nausea and Vomiting (CINV) report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Chemotherapy-Induced Nausea and Vomiting (CINV) report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Closed Stopcocks

Closed Stopcocks market is segmented by Type and by Application. Players, stakeholders, and other ... Read More

High Flow Stopcocks

High Flow Stopcocks market is segmented by Type and by Application. Players, stakeholders, and ot ... Read More